Developing Breakthrough Therapy to Reverse Disability After Stroke
Novel, AI-powered, tailored electromagnetic stimulation aimed to help you achieve freedom from disability following a stroke from the comfort of your home
Proud to collaborate with esteemed research and medical institutions
.avif)
1 in 4
Adults will experience a stroke in their lifetime*
* Feigin, Valery L., et al. "World Stroke Organization (WSO): global stroke fact sheet 2022." International Journal of Stroke 17.1 (2022): 18-29
** Lee, Kyoung Bo, et al. "Six-month functional recovery of stroke patients: a multi-time-point study." International journal of rehabilitation research 38.2 (2015): 173-180
60%
of stroke survivors face life-debilitating long-term disability**
Rehabilitationverse
‘Freedom From Disability’ is the ultimate goal for stroke survivors
Our investigational therapy has already demonstrated promising results in regaining 'freedom from disability' in well-designed studies
Granted FDA Breakthrough Device Designation
Investigational Device designed for safe use wherever you are, in the clinic or at home.
Brain Relearning. Reimagined with AI.
BRAIN.Q relies on emerging science suggesting the use of targeted stimulation of network activity as a key for maximizing the brain's learning capabilities.
Our breakthrough investigational therapy is designed to use AI to distill neural activity patterns by analyzing datasets of network activity.
These patterns are then applied to patients through tailored, low-intensity, low frequency electromagnetic stimulation that aims to enhance and accelerate the brain's recovery process after stroke.
Defying Stroke Takes Real Bravery
No two journeys to recovery are the same. Our investigational therapy is designed to support our heroes on their individual paths, every step of the way, whether they are in the clinic or at home.
Learn more about the patient experience from our first participant in our EMAGINE clinical trial
Awards & Recognition
BRAIN.Q named Technology Pioneer in the World Economic Forum's 2024 Cohort
.png)
Granted FDA Breakthrough Device Designation
Recognized as a "ground-breaking" innovation and received funding from the European Union’s Horizon 2020 research and innovation program
BRAIN.Q Named to Fast Company's "Next Big Things in Tech" list
Named one of the most promising startups in Israel by Calcalist and Microsoft in 2018
IBM Alpha Zone Accelerator
One of four startups invited to participate in Google Developers Launchpad Studio's AI program
2nd place in the AI category in the China (Shenzen) Int. Innovation & Entrepreneurship International Competition
BRAIN.Q named "Best New Technology Solution - Therapeutic" in the 2024 Medtech Breakthrough Awards
Quest for Brain Health
As we age, brain health emerges as the greatest challenge for each of us.
BRAIN.Q symbolizes our devotion to navigating this quest with humility and persistence, with the goal of enhancing brain health.
As the first steps in this quest, BRAIN.Q has successfully conducted several clinical and preclinical studies in a variety of neurological conditions with the goal of improving patient outcomes.
